ArticleGene therapy2013
Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency.
W Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papercites it